A major effect of STAT3 targeting in HCC was increased expression of NKG2D ligands ULBP1, ULBP2, and ULBP3, and enhanced NK-mediated killing of STAT3-targeted HCC cells was partially reversed by treatment with an anti-ULBP3 neutralizing antibody. This evidence concerns the gene ULBP2 and hepatocellular carcinoma.